Back to Search Start Over

Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

Authors :
Seyed Ramin Radfar
Cornelis A. J. De Jong
Ali Farhoudian
Mohsen Ebrahimi
Parnian Rafei
Mehrnoosh Vahidi
Masud Yunesian
Christos Kouimtsidis
Shalini Arunogiri
Omid Massah
Abbas Deylamizadeh
Kathleen T. Brady
Anja Busse
ISAM-PPIG Global Survey Consortium
Marc N. Potenza
Hamed Ekhtiari
Alexander Mario Baldacchino
Adrian Octavian Abagiu
Franck David Noel Abouna
Mohamed Hassan Ahmed
Basma Al-ansari
Feda Mahmmoud Abu Al-khair
Mandhar Humaid Almaqbali
Atul Ambekar
Hossein Mohaddes Ardabili
Sidharth Arya
Victor Olufolahan Lasebikan
Murad Ali Ayasreh
Debasish Basu
Zoubir Benmebarek
Roshan Bhad
Mario Blaise
Nicolas Bonnet
Jennifer Brasch
Barbara Broers
Jenna L. Butner
Moses Camilleri
Giovanna Campello
Giuseppe Carra
Ivan Celic
Fatemeh Chalabianloo
Abhishek Chaturvedi
José de Jesús Eduardo Noyola Cherpitel
Kelly J. Clark
Melissa Anne Cyders
Ernesto de Bernardis
John Edward Derry
Naveen Kumar Dhagudu
Pavla Dolezalova
Geert Dom
Adrian John Dunlop
Mahmoud Mamdouh Elhabiby
Hussien Elkholy
Nsidibe Francis Essien
Ghandi Ilias Farah
Marica Ferri
Georgios D Floros
Catherine Friedman
Clara Hidalgo Fuderanan
Gilberto Gerra
Abhishek Ghosh
Maka Gogia
Ilias A. Grammatikopoulos
Paolo Grandinetti
Amira Guirguis
David Gutnisky
Paul Steven Haber
Peyman Hassani-Abharian
Zahra Hooshyari
Islam Ibrahim Mokhtar Ibrahim
Hada Fong-ha Ieong
Regina Nova Indradewi
Shelly Iskandar
Shobhit Jain
Sandi James
Seyyed Mohammad hossein Javadi
Keun Ho Joe
Darius Jokubonis
Acka Tushevska Jovanova
Rama Mohamed Kamal
Alexander Ivanov Kantchelov
Preethy Kathiresan
Gary Katzman
Paul Kawale
Audrey Margaret Kern
Felix Henrique Paim Kessler
Sung-Gon Sue Kim
Ann Marie Kimball
Zeljko Kljucevic
Kristiana Siste
Roneet Lev
Hae Kook Lee
Aiste Lengvenyte
Shaul Lev-ran
Geni Seseja Mabelya
Mohamed Ali El Mahi
J. Maphisa Maphisa
Icro Maremmani
Laura Masferrer
Orlagh McCambridge
Garrett Gregory McGovern
Aung Kyi Min
Amir Moghanibashi-Mansourieh
Jazman Mora-Rios
Indika Udaya Kumara Mudalige
Diptadhi Mukherjee
Pejic Munira Munira
Bronwyn Myers
Jayakrishnan Menon T N
Venkata Lakshmi Narasimha
Nkemakolam Ndionuka
Ali-Akbar Nejatisafa
Kamran Niaz
Asad Tamizuddin Nizami
Jan H. Nuijens
Laura Orsolini
Vantheara Oum
Adegboyega Adekunle Oyemade
Irena Rojnia Palavra
Sagun Ballav Pant
Joselyn Paredes
Eric Peyron
Randall Alberto Quirós
Rouhollah Qurishi
Noor ul Zaman Rafiq
Ranjini Raghavendra Rao
Woraphat Ratta-apha
Karren-Lee Raymond
Jens Reimer
Eduardo Renaldo
Tara Rezapour
James Roy Robertson
Carlos Roncero
Fazle Roub
Elizabeth Jane Rubenstein
Claudia Ines Rupp
Elizabeth Saenz
Mohammad Salehi
Lampros Samartzis
Laura Beatriz Sarubbo
Nusa Segrec
Bigya Shah
Hongxian Shen
Tomohiro Shirasaka
Steve Shoptaw
Fransiskus Muronga Sintango
Veronica Andrea Sosa
Emilis Subata
Norberto Sztycberg
Fatemeh Taghizadeh
Joseph Brian Tay Wee Teck
Christian Tjagvad
Marta Torrens
Judith Meme Twala
Ramyadarshni Vadivel
Joseph Robert Volpicelli
Jelmer Weijs
Steven Michael Wintoniw
Apisak Wittayanookulluk
Marcin Wojnar
Sadia Yasir
Yimenu Yitayih
Min Zhao
Arash Khojasteh Zonoozi
Source :
Frontiers in Psychiatry, Vol 12 (2021)
Publication Year :
2021
Publisher :
Frontiers Media S.A., 2021.

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic.Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups.Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted.Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.

Details

Language :
English
ISSN :
16640640
Volume :
12
Database :
Directory of Open Access Journals
Journal :
Frontiers in Psychiatry
Publication Type :
Academic Journal
Accession number :
edsdoj.46448e8badc5461abef1fae8f9a510e2
Document Type :
article
Full Text :
https://doi.org/10.3389/fpsyt.2021.639393